Nuveen Asset Management LLC lowered its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Rating) by 3.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,241,754 shares of the real estate investment trust's stock after selling 50,426 shares during the period. Nuveen Asset Management LLC owned 0.54% of Sabra Health Care REIT worth $16,292,000 at the end of the most recent quarter.
→ Free Stock Analysis Report: See the Right Way to Analyze Stocks (From Vector Vest)
Several other large investors also recently made changes to their positions in SBRA. Waterfront Capital Partners LLC grew its holdings in Sabra Health Care REIT by 28.0% during the third quarter. Waterfront Capital Partners LLC now owns 1,470,100 shares of the real estate investment trust's stock worth $19,288,000 after purchasing an additional 321,585 shares during the period. UBS Oconnor LLC boosted its stake in shares of Sabra Health Care REIT by 3.1% during the 3rd quarter. UBS Oconnor LLC now owns 251,789 shares of the real estate investment trust's stock worth $3,303,000 after acquiring an additional 7,544 shares during the period. MetLife Investment Management LLC increased its holdings in shares of Sabra Health Care REIT by 1.2% during the 3rd quarter. MetLife Investment Management LLC now owns 266,503 shares of the real estate investment trust's stock worth $3,497,000 after acquiring an additional 3,241 shares during the last quarter. Hsbc Holdings PLC raised its stake in Sabra Health Care REIT by 118.9% in the 3rd quarter. Hsbc Holdings PLC now owns 107,073 shares of the real estate investment trust's stock valued at $1,402,000 after acquiring an additional 58,157 shares during the period. Finally, Brown Advisory Inc. acquired a new stake in Sabra Health Care REIT during the 3rd quarter valued at $172,000. Institutional investors and hedge funds own 87.20% of the company's stock.
NASDAQ SBRA opened at $12.02 on Monday. The firm has a 50-day moving average price of $12.91 and a two-hundred day moving average price of $13.20. Sabra Health Care REIT, Inc. has a 12-month low of $11.44 and a 12-month high of $16.60. The company has a debt-to-equity ratio of 0.82, a current ratio of 3.27 and a quick ratio of 3.27.
The business also recently declared a quarterly dividend, which was paid on Tuesday, February 28th. Investors of record on Monday, February 13th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 9.98%. The ex-dividend date of this dividend was Friday, February 10th. Sabra Health Care REIT's dividend payout ratio (DPR) is currently -352.93%.
Several research firms have commented on SBRA. Bank of America downgraded shares of Sabra Health Care REIT from a "neutral" rating to an "underperform" rating and decreased their price objective for the company from $15.00 to $13.00 in a report on Monday, November 14th. JMP Securities cut shares of Sabra Health Care REIT from an "outperform" rating to a "market perform" rating in a report on Tuesday, December 13th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $14.50.
Sabra Health Care REIT, Inc engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
